Tissue Regenix Group Share News (TRX)

Tissue Regenix's losses widen as company pushes towards significant milestones

(ShareCast News) - AIM-listed regenerative medical devices company Tissue Regenix Group's saw operating losses widen at the interim stage even as its revenues nudged higher, although it did gain regulatory approval for its products in Europe and the US. For the six months ended 31 July, revenue incr

Tissue Regenix Loss Widens But Revenue Grows On Portfolio Progress

UK Earnings, Trading Statements Calendar - Next 7 Days

Tissue Regenix Gets Coverage For DermaPure In 10 Further US States

Tissue Regenix's devices a step closer to product launch

(ShareCast News) - Regenerative medical device company Tissue Regenix released an update on two of its devices for a potential pilot study and product launch. The AIM listed company is currently undertaking clinical trials within the European Union for OrthoPure XT and OrthoPure XM products. The co

Tissue Regenix Makes OrthoPure Progress In Europe And US

Tissue Regenix Wins DermaPure Deal With US Purchasing Organisation

UK Shareholder Meetings Calendar - Next 7 Days

Tissue Regenix Sees Loss Widen On Roll Out Of DermaPure Product In US

Earnings, Trading Statements Calendar - Week Ahead

BROKER RATINGS SUMMARY: Macquarie And Morgan Stanley Downgrade Miners

Tissue Regenix Makes Progress On DermaPure, SurgiPure Products In US

Tissue Regenix announces German joint venture

(ShareCast News) - Tissue Regenix announced its first step towards the commercialisation of two of its products on Tuesday, through a joint venture agreement with a German tissue bank. The AIM-listed company said it had entered into an agreement with GTM-V to form a venture called GBM-V, a tissue ba

Tissue Regenix Inks Joint Venture Deal For German Tissue Bank

WINNERS & LOSERS SUMMARY: WH Smith Up, Wetherspoons Down After Updates